139 related articles for article (PubMed ID: 14654959)
1. Immunohistochemical aid at risk stratification of melanocytic neoplasms.
Quatresooz P; Arrese JE; Pierard-Franchimont C; Pierard GE
Int J Oncol; 2004 Jan; 24(1):211-6. PubMed ID: 14654959
[TBL] [Abstract][Full Text] [Related]
2. [Reactivity of five different antibodies with benign and malignant melanocytic lesions].
Plótár V; Szentirmay Z; Orosz Z
Magy Onkol; 2008 Dec; 52(4):363-73. PubMed ID: 19068464
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemistry in the evaluation of melanocytic tumors.
Ruiter DJ; Bröcker EB
Semin Diagn Pathol; 1993 Feb; 10(1):76-91. PubMed ID: 8506418
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical expression of nm23 in primary invasive malignant melanoma is predictive of survival outcome.
McDermott NC; Milburn C; Curran B; Kay EW; Barry Walsh C; Leader MB
J Pathol; 2000 Feb; 190(2):157-62. PubMed ID: 10657013
[TBL] [Abstract][Full Text] [Related]
5. [Proliferative nodule in a congenital melanocytic nevus].
López V; Martín JM; Jordá E
Actas Dermosifiliogr; 2010; 101(1):102-3. PubMed ID: 20109406
[No Abstract] [Full Text] [Related]
6. Comparison of pHH3, Ki-67, and survivin immunoreactivity in benign and malignant melanocytic lesions.
Nasr MR; El-Zammar O
Am J Dermatopathol; 2008 Apr; 30(2):117-22. PubMed ID: 18360113
[TBL] [Abstract][Full Text] [Related]
7. Statistical analysis of the concordance of immunohistochemical stains with the final diagnosis in spitzoid neoplasms.
Puri PK; Ferringer TC; Tyler WB; Wilson ML; Kirchner HL; Elston DM
Am J Dermatopathol; 2011 Feb; 33(1):72-7. PubMed ID: 20700039
[TBL] [Abstract][Full Text] [Related]
8. Oral alveolar soft-part sarcoma: review of literature and case report with immunohistochemistry study for prognostic markers.
do Nascimento Souza KC; Faria PR; Costa IM; Duriguetto AF; Loyola AM
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2005 Jan; 99(1):64-70. PubMed ID: 15599350
[TBL] [Abstract][Full Text] [Related]
9. HMB-45 and Melan-A are useful in the differential diagnosis between granular cell tumor and malignant melanoma.
Gleason BC; Nascimento AF
Am J Dermatopathol; 2007 Feb; 29(1):22-7. PubMed ID: 17284958
[TBL] [Abstract][Full Text] [Related]
10. Relationship of nm23 expression to proliferation and prognosis in malignant melanomas of the oral cavity.
Korabiowska M; Hönig JF; Jawien J; Knapik J; Stachura J; Cordon-Cardo C; Fischer G
In Vivo; 2005; 19(6):1093-6. PubMed ID: 16277028
[TBL] [Abstract][Full Text] [Related]
11. Accurate identification of proliferative index in melanocytic neoplasms with Melan-A/Ki-67 double stain.
Puri PK; Valdes CL; Burchette JL; Grichnik JM; Turner JW; Selim MA
J Cutan Pathol; 2010 Sep; 37(9):1010-2. PubMed ID: 20002650
[No Abstract] [Full Text] [Related]
12. S-100 protein-negative malignant melanoma: fact or fiction? A light-microscopic and immunohistochemical study.
Argenyi ZB; Cain C; Bromley C; Nguyen AV; Abraham AA; Kerschmann R; LeBoit PE
Am J Dermatopathol; 1994 Jun; 16(3):233-40. PubMed ID: 7943629
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical characteristics of melanoma.
Ohsie SJ; Sarantopoulos GP; Cochran AJ; Binder SW
J Cutan Pathol; 2008 May; 35(5):433-44. PubMed ID: 18399807
[TBL] [Abstract][Full Text] [Related]
14. [Monoclonal antibody HMB-45 in diagnosis of intra-ocular melanoma].
Rohrbach JM; Steuhl KP; Thanos S
Klin Monbl Augenheilkd; 1991 Oct; 199(4):274-7. PubMed ID: 1762354
[TBL] [Abstract][Full Text] [Related]
15. Glycoconjugate profiling of primary melanoma and its sentinel node and distant metastases: implications for diagnosis and pathophysiology of metastases.
Thies A; Berlin A; Brunner G; Schulze HJ; Moll I; Pfüller U; Wagener C; Schachner M; Altevogt P; Schumacher U
Cancer Lett; 2007 Apr; 248(1):68-80. PubMed ID: 16822608
[TBL] [Abstract][Full Text] [Related]
16. Highly sensitive multivariable assay detection of melanocytic differentiation antigens and angiogenesis biomarkers in sentinel lymph nodes with melanoma micrometastases.
Vitoux D; Mourah S; Kerob D; Verola O; Basset-Seguin N; Baccard M; Schartz N; Ollivaud L; Archimbaud A; Servant JM; Revol M; Toubert ME; Podgorniak MP; Plassa F; Porcher R; Lebbé C
Arch Dermatol; 2009 Oct; 145(10):1105-13. PubMed ID: 19841396
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical evaluation of necrotic malignant melanomas.
Nonaka D; Laser J; Tucker R; Melamed J
Am J Clin Pathol; 2007 May; 127(5):787-91. PubMed ID: 17439838
[TBL] [Abstract][Full Text] [Related]
18. Dermatopathological indicators of poor melanoma prognosis are significantly inversely correlated with the expression of NM23 protein in primary cutaneous melanoma.
Ferrari D; Lombardi M; Ricci R; Michiara M; Santini M; De Panfilis G
J Cutan Pathol; 2007 Sep; 34(9):705-12. PubMed ID: 17696918
[TBL] [Abstract][Full Text] [Related]
19. Tumor characteristics involved in the metastatic behaviour as an improvement in primary cutaneous melanoma prognostics.
Goldmann T; Ribbert D; Suter L; Brode M; Otto F
J Exp Clin Cancer Res; 1998 Dec; 17(4):483-9. PubMed ID: 10089072
[TBL] [Abstract][Full Text] [Related]
20. DMBT1 expression distinguishes anorectal from cutaneous melanoma.
Helmke BM; Renner M; Poustka A; Schirmacher P; Mollenhauer J; Kern MA
Histopathology; 2009 Jan; 54(2):233-40. PubMed ID: 19207948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
